About: Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.
Sector: Healthcare
Industry: Diagnostics & Research
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
MYNZ NASDAQ Mainz Biomed BV
Mainz Biomed BV share price
MYNZ price activity
Last Price
Change (24hr)
USD
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
MYNZ price performance
MYNZ details
MYNZ Market Signals